PG - The Procter & Gamble Company
NEXT EARNINGS:
Apr 17, 2026
EPS Est: $1.57
|
Rev Est: $20.6B
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$167.67
DETAILS
HIGH:
$179.00
LOW:
$150.00
MEDIAN:
$172.50
CONSENSUS:
$167.67
UPSIDE:
1.45%
Market Cap:
386.22B
Volume:
7,597,876
Avg Volume:
11,372,593
52 Week Range:
137.62-179.99
Sector:
Consumer Defensive
Industry:
Household & Personal Products
Beta:
0.38
Last Dividend:
$4.23
Exchange:
NYSE
Country:
US
Employees:
108,000
IPO Date:
1978-01-13
EPS (TTM):
6.67
P/E Ratio:
24.48
Revenue (TTM):
84.28B
Total Assets:
125.23B
Total Debt:
35.46B
Cash & Equiv:
9.56B
Rev Growth (5Y):
3.5%
EPS Growth (5Y):
5.4%
FCF Growth (5Y):
-0.4%
ROCE:
23.6%
Debt/Equity:
0.68
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2026-01-22 | $1.88 | $1.86 | +1.1% | $22.2B | $22.3B | -0.4% |
| 2025-10-24 | $1.99 | $1.90 | +4.7% | $22.4B | $22.2B | +0.9% |
| 2025-07-29 | $1.48 | $1.42 | +4.2% | $20.9B | $20.8B | +0.2% |
| 2025-04-24 | $1.54 | $1.52 | +1.3% | $19.8B | $20.2B | -1.9% |
| 2025-01-22 | $1.88 | $1.89 | -0.5% | $21.9B | $21.6B | +1.4% |
| 2024-10-18 | $1.93 | $1.90 | +1.6% | $21.7B | $22.0B | -1.1% |
| 2024-07-30 | $1.40 | $1.37 | +2.2% | $20.5B | $20.7B | -0.9% |
| 2024-04-19 | $1.52 | $1.41 | +7.8% | $20.2B | $20.4B | -1.2% |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 84.28B | 84.04B | 82.01B | 80.19B | 76.12B | 70.95B | 67.68B | 66.83B | 65.06B | 65.30B | 70.75B | 74.40B |
| Net Income | 15.97B | 14.88B | 14.65B | 14.74B | 14.31B | 13.03B | 3.90B | 9.75B | 15.33B | 10.51B | 7.04B | 11.64B |
| EPS | 6.67 | 6.18 | 6.07 | 6.00 | 5.69 | 5.13 | 1.45 | 3.75 | 5.80 | 3.80 | 2.50 | 4.19 |
| Total Assets | 125.23B | 122.37B | 120.83B | 117.21B | 119.31B | 120.70B | 115.09B | 118.31B | 120.41B | 127.14B | 129.50B | 144.27B |
| Total Debt | 35.46B | 33.37B | 35.42B | 32.29B | 32.84B | 35.61B | 30.10B | 31.39B | 31.64B | 30.64B | 30.40B | 35.50B |
| Cash & Equivalents | 9.56B | 9.48B | 8.25B | 7.21B | 10.29B | 16.18B | 4.24B | 2.57B | 5.57B | 7.10B | 6.84B | 8.56B |
| Operating Cash Flow | 17.82B | 19.85B | 16.85B | 16.72B | 18.37B | 17.40B | 15.24B | 14.87B | 12.75B | 15.44B | 14.61B | 13.96B |
| Free Cash Flow | 14.04B | 16.52B | 13.79B | 13.57B | 15.58B | 14.33B | 11.89B | 11.15B | 9.37B | 12.12B | 10.87B | 10.11B |
| FCF per Share | 5.72 | 7.00 | 5.82 | 5.52 | 6.20 | 5.64 | 4.75 | 4.41 | 3.61 | 4.38 | 3.86 | 3.64 |
| Book Value | 52.01B | 50.29B | 46.78B | 46.59B | 46.38B | 46.52B | 47.19B | 52.29B | 55.18B | 57.34B | 62.42B | 69.21B |
| Cash & ST Investments | 9.56B | 9.48B | 8.25B | 7.21B | 10.29B | 16.18B | 10.29B | 11.85B | 15.14B | 13.35B | 11.60B | 10.69B |
| ROC Equity | 0.31 | 0.30 | 0.31 | 0.32 | 0.31 | 0.28 | 0.08 | 0.19 | 0.28 | 0.18 | 0.11 | 0.17 |